Ingredients. All ingredients namely, cement, sand, coarse aggregate and water shall comply with the specifications already listed.
Ingredients. The diluent is an AMP, bicine, barbital, aspartate buffer with sodium azide added as a preservative. WARNING: FOR IN-VITRO DIAGNOSTIC USE ONLY. DO NOT INGEST. Refer to Sodium Azide Warning.
Ingredients. In the AAA-provider agreement, the AAA shall indicate the method by which the provider shall offer ingredient information on the meals provided to consumers.
Ingredients. For raw materials, master batches, fillers, inserts and packaging are the prices generally established on an annual basis. Yearly we can negotiate for standard ingredients with the help of our provisions for annual contracts. For custom made products, such as inserts we need to keep our project price due to be in line with our customer project price. Quadrant CMS wish to receive the best prices on first quotations.
Ingredients. Xxxxxx agrees to use the New Ingredient Declaration whenever an ingredient declaration is used. Warning: For external use. Avoid getting in eyes; if so, immediately rinse thoroughly with cool water. Not for use by customers under the age of 18. Do not use on damaged or irritated skin, if pregnant or nursing or undergoing treatment for glaucoma or cancer. Not recommended if you have ever experienced dry eyes, eye infections, styes or any other eye-related disorder. If redness, irritation or other unwanted effects occur, stop using product immediately. If symptoms persist, seek medical attention. Keep out of reach of children. Warning: For external use. Avoid getting in eyes; if so, immediately rinse thoroughly with cool water. Not for use by customers under the age of 18. Do not use on damaged or irritated skin, if pregnant or nursing, undergoing treatment for glaucoma or cancer or if you are being treated for a facial skin condition. If redness, irritation or other unwanted effects occur, stop using product immediately. If symptoms persist, seek medical attention. Keep out of reach of children. Warning: For external use. Avoid getting in eyes; if so, immediately rinse thoroughly with cool water. Not for use by customers under the age of 18. Do not use on damaged or irritated skin, if pregnant or nursing, undergoing treatment for glaucoma or cancer, or if you are being treated for a scalp condition. If redness, irritation or other unwanted effects occur, stop using product immediately. If symptoms persist, seek medical attention. Keep out of reach of children. Directions: As with all cosmetic products used in the area of the eye (or close proximity to the eye), it is important to carefully read all directions and warnings. Carefully apply GrandeLASH- MD once daily on a clean, dry upper lash line only using a single stroke on your eyelid just above your upper lash line (like a liquid eyeliner). Do not apply to the lower lash line. Apply only with the product applicator provided. Use one dip into the bottle for both upper lash lines and allow 2-3 minutes for the serum to fully dry before lying down or applying other products to your eye area. Use sparingly. If serum gets into the eye, immediately rinse thoroughly with cool water to completely remove serum from the eye. Apply every day for a full 3 months. After desired improvement is achieved, apply every other day for maintenance. GrandeLASH-MD requires continued use to maintain benefits. This cosmetic produ...
Ingredients. The powder contains anionic and nonionic surfactants, sodium carbonate, enzymes and sodium chloride Preparation for Use: Dissolve the powder in 8 L of deionized water and mix thoroughly. Storage and Stability: Store the dry powder at 15 to 30°C until the expiration date indicated on the label. The dissolved solution is stable for 1 month when stored at 15 to 30°C. Signs of Deterioration: The dissolved solution should be discarded if it shows signs of bacterial contamination.
Ingredients. The buffer is a tris-barbital-sodium barbital buffer. WARNING: FOR IN-VITRO DIAGNOSTIC USE. DO NOT INGEST. The buffer contains barbital which, in sufficient quantity, can be toxic. Preparation for Use: Dissolve one package in 750 mL deionized water. The buffer is ready for use when all material is completely dissolved. Storage and Stability: The packaged buffer should be stored at 15 to 30°C and is stable until the expiration date indicated on the package. Diluted buffer is stable for two months at 15 to 30°C. Signs of Deterioration: Discard packaged buffer if the material shows signs of dampness or discoloration. Discard diluted buffer if it becomes turbid.
Ingredients. (1) The Producer must grow, raise or catch the ‘defining ingredient(s)’ in the processed food item. (Some examples of ‘defining ingredient’ in a product: clams in clam chowder, tomato in tomato sauce, basil in pesto, beef in beef stew, vegetables in vegetable soup.)
(2) Any additional ingredients must be directly obtained from the Regional farms where grown and processed, except as indicated below.
(3) Supplemental quantities of the following ingredients may be used without limitation as to source: soy sauce, vinegar, fresh citrus fruit, seeds or nuts, cornstarch or thickeners, gypsum or nigari, salt, oil, fat, sweeteners or spices. Ingredients not specifically listed here must be approved by the Director, review by the FCAC may be requested.
Ingredients. (1) The Producer must grow, raise, or catch the ‘defining ingredient’ (e.g., clams in clam chowder, tomato in tomato sauce, basil in pesto, beef in beef stew).
(2) Any additional ingredients must be directly obtained from the Regional farms where grown and processed, except as indicated below:
(3) Supplemental quantities of the following ingredients may be used without limitation as to source: soy sauce, vinegar, fresh citrus fruit, seeds or nuts, cornstarch or thickeners, gypsum or nigari, salt, oil, fat, sweeteners or spices. Ingredients not specifically listed here must be approved by the Director, review by the FCAC may be requested.
Ingredients. Fungal Oil; * -* The asterisk denotes that confidential portions of this exhibit have been omitted in reliance on Rule 24b-2 of the Securities Exchange Act of 1934. The confidential portions have been submitted separately to the Securities and Exchange Commission.
